Jason Kelly Biography and Net Worth

Chief Operations and Quality Officer of Inspire Medical Systems

Jason Kelly has served as Chief Operations and Quality Officer since January 2025. Prior to Inspire, he served in various operations and new product development roles at Stryker Corporation since 2006, most recently as Vice President of Division Operations. Jason holds a Bachelor’s degree in Manufacturing Engineering and a Diploma in Quality Management from the University of Limerick, as well as a Diploma in Mechanical Engineering from the Cork Institute of Technology.

What is Jason P. Kelly's net worth?: The estimated net worth of Jason P. Kelly is at least $1.12 million as of August 7th, 2026. Mr. Kelly owns 18,985 shares of Inspire Medical Systems stock worth more than $1,124,918 as of August 12th. This net worth estimate does not reflect any other investments that Mr. Kelly may own. Learn More about Jason P. Kelly's net worth.
How do I contact Jason P. Kelly?: The corporate mailing address for Mr. Kelly and other Inspire Medical Systems executives is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. Inspire Medical Systems can also be reached via phone at (844) 672-4357 and via email at [email protected]. Learn More on Jason P. Kelly's contact information.
Has Jason P. Kelly been buying or selling shares of Inspire Medical Systems?: During the last ninety days, Jason P. Kelly has sold $57,346.65 in Inspire Medical Systems stock. Most recently, Jason P. Kelly sold 963 shares of the business's stock in a transaction on Friday, August 7th. The shares were sold at an average price of $59.55, for a transaction totalling $57,346.65. Following the completion of the sale, the insider now directly owns 18,985 shares of the company's stock, valued at $1,130,556.75. Learn More on Jason P. Kelly's trading history.
Who are Inspire Medical Systems' active insiders?: Inspire Medical Systems' insider roster includes Randy Ban (Insider), Richard Buchholz (CFO), Myriam Curet (Director), Philip Ebeling (COO), Jerry Griffin (Director), Timothy Herbert (CEO), Steven Jandrich (VP), Jason Kelly (Chief Operations and Quality Officer), Chau Khuong (Director), Shawn McCormick (Director), Georgia Melenikiotou (Director), Marilyn Nelson (Director), John Rondoni (CTO), and Casey Tansey (Director). Learn More on Inspire Medical Systems' active insiders.
Are insiders buying or selling shares of Inspire Medical Systems?: In the last year, insiders at the sold shares 4 times. They sold a total of 14,072 shares worth more than $1,350,496.65. The most recent insider tranaction occured on August, 7th when insider Jason P Kelly sold 963 shares worth more than $57,346.65. Insiders at Inspire Medical Systems own 2.2% of the company. Learn More about insider trades at Inspire Medical Systems.
Information on this page was last updated on 8/7/2026.

Jason P. Kelly Insider Trading History at Inspire Medical Systems

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/7/2026	Sell	963	$59.55	$57,346.65	18,985

Jason P. Kelly Buying and Selling Activity at Inspire Medical Systems

Inspire Medical Systems Company Overview

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Today's Range

Now: $58.11

$57.20

$59.12

50 Day Range

MA: $48.39

$40.42

$64.08

2 Week Range

Now: $58.11

$38.91

$147.03

Volume

117,155 shs

Average Volume

1,150,241 shs

Market Capitalization

$1.68 billion

P/E Ratio

12.57

Dividend Yield

N/A

Beta

0.7